Pratsepaami

Prazepam is a long-acting benzodiazepine prodrug that metabolizes into desmethyldiazepam (nordazepam), which has a very long half-life and is responsible for most therapeutic effects. This results in prolonged duration and potential for accumulation with repeated dosing. Tolerance, dependence, and benzodiazepine withdrawal syndrome are significant risks with long-term use. Abrupt discontinuation after extended use can be dangerous and may cause seizures. Not recommended for individuals with respiratory depression, substance abuse history, or during pregnancy.

Also known as: Reapam, Centrac, Centrax, Pozapam, Prazene, Lysanxia, Demetrin, Sedapran, Trepidan, Prazepamum

Classification

Chemical: Benzodiazepine
Chemical: Medicine
Psychoactive: Depressant
Tag: Anxiolytic
Tag: GABAergic
Tag: Habit-Forming
Tag: Muscle Relaxant
Tag: Sedative

Effects

Sedation
Muscle Relaxation
Motor Control Impairment
Anxiolytic
Anticonvulsant
Sedative
Anxiety Suppression
Cognitive Impairment
Drowsiness
Amnesia
Emotion Suppression
Delusions Of Sobriety
Disinhibition
Dulled Perception

Routes of Administration

Oral

Dosage

Threshold: 5 mg
Light: 5-10 mg
Common: 10-30 mg
Strong: 20-40 mg
Heavy: 60+ mg

Duration

Onset: 0.5-1.5 h
Comeup: 1-2 h
Peak: 2-6 h
Offset: 12-24 h
After Effects: 24-72 h
Total Duration: 8-24 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu